Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | -7.19% | -2.17% | -19.35% |
May. 02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.35% | 263M | |
+2.93% | 108B | |
-4.22% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q3 Revenue $116.3M